Method for assaying photosensitizing drug in whole blood
OwnerAvigdor M. Ronninventor
Life of this patent
Estimating the term…
Abstract
A concentration of a photosensitizing drug in a patient, for PhotoDynamic Therapy treatment of the patient by a treatment light at a treatment light wavelength, is determined by the steps of drawing a blood sample from the patient, diluting the blood sample to form a diluted sample, irridating the diluted sample with an interrogation light at an interrogation wavelength range at an absorption band bluer than the treatment light wavelength, measuring a magnitude of an emission signal at the treatment light wavelength, the emission signal caused by the irradiation of the diluted sample, and comparing the measured magnitude to a magnitude/concentration calibration curve to determine the concentration of the photosensitizing drug.
Claims18
A method for determining a concentration of a photosensitizing drug in a patient, for PhotoDynamic Therapy treatment of said patient by a treatment light at a treatment light wavelength, said method comprising the steps of:
- drawing a whole blood sample from said patient;
- diluting said whole blood sample to form a diluted sample containing some amount of a photosensitizing drug including none;
- irradiating said diluted sample with an interrogation light in an interrogation wavelength range of an absorption band, of said photosensitizing drug, bluer than said treatment light wavelength;
- measuring a magnitude of an emission signal at said treatment light wavelength, said emission signal caused by said irradiation of said diluted sample;
- and
- comparing said measured magnitude to a magnitude/concentration calibration curve to determine the concentration of said photosensitizing drug.
A method for determining a concentration of a photosensitizing drug in a patient, for PhotoDynamic Therapy treatment of said patient by a treatment light at a treatment light wavelength, said method comprising the steps of:
- drawing a whole blood sample from said patient;
- diluting said whole blood sample by a dilution factor to produce a diluted sample containing some amount of a photosensitizing drug including none, said dilution factor effective to cause said diluted sample to emit a measurable emission signal at said treatment light wavelength when irradiated by an interrogation wavelength range at an absorption band bluer than said treatment light wavelength;
- irradiating said diluted sample with an interrogation light at said interrogation wavelength range;
- measuring a magnitude of said measurable emission signal at said treatment light wavelength, said measurable emission signal caused by said irradiation of said diluted sample;
- and
- comparing said measured magnitude to a magnitude/concentration calibration curve to determine the concentration of said photosensitizing drug.
A method for determining a concentration of a photosensitizing drug in a patient, for PhotoDynamic Therapy treatment of said patient by a treatment light at a treatment light wavelength, said method comprising the steps of:
- drawing a calibrated whole blood sample from said patient;
- diluting said whole calibrated blood sample to a calibrated dilution to produce a diluted sample containing some amount of a photosensitizing drug including none, said calibrated dilution effective to cause said diluted sample to emit a measurable emission signal at said treatment light wavelength when irradiated by an interrogation wavelength range at an absorption band bluer than said treatment light wavelength;
- irradiating said diluted sample with an interrogation light at said interrogation wavelength range;
- measuring a magnitude of said measurable emission signal at said treatment light wavelength, said measurable emission signal caused by said irradiation of said diluted sample;
- and
- comparing said measured magnitude to a magnitude/concentration calibration curve to determine the concentration of said photosensitizing drug.
Dependencies are inferred from the claim text.